Category Archives: Biopharma

Specialty Pharmaceutical Hub Services News Roundup: July 2023

AMI’s annual Specialty Hub Service Providers Report provides comprehensive business intelligence on more than 70 companies

Employer Plans View Product Coverage Very Differently from PBMs

Employers’ benefit coverage decisions and the impact those decisions have on the market for rare disease / orphan drugs are a growing concern for biopharma companies

VHA Will Provide Coverage for Leqembi to Qualified Veterans with Early Alzheimer’s Disease

VHA Will Provide Coverage for Leqembi to Qualified Veterans with Early Alzheimer’s Disease, while the CMS continues to restrict its use

Did You Know Market Access is Closing Down

Biopharma companies need to see the employer market clearly in the short and long-term to be able to understand payers management methods for orphan drugs and the impact those decisions will have on their drugs

Cigna Restricts Coverage for Amylyx Pharmaceutical’s ALS Drug Relyvrio

Cigna restricts coverage for Amylyx Pharmaceutical’s ALS drug Relyvrio due to the lack of clinical efficacy data and unclear clinical benefit

Independence Blue Cross Launches Gene Therapeutics Network

BlueCross Blue Shield Plans: Access Market Intelligence

Independence Blue Cross (Independence) recently announced the launch of its Advanced Network for Gene-Based Therapeutics, which will be effective March 1, 2023

McKesson Acquires Rx Savings Solutions To Support Biopharma Services Growth

McKesson to acquire RxSS, a prescription price transparency and benefit insight company that offers affordability and adherence solutions to health plans and employers, reaching more than 17 million current patients

United BioSource Expands Capabilities for Biopharmaceutical Clients

This year, UBC has partnered with Seqster and acquired Marketshare Movers to advance the company’s capabilities in clinical trials and co-pay and affordability programs